EXTROVIS AG

Extrovis is an Indo-Swiss global CRDMO committed to the successful delivery of innovative and complex therapeutics to patients worldwide. Our global team, of scientific and manufacturing experts brings decades of experience, supported by state-of-the-art manufacturing infrastructure across India, Europe, and the United States.

Extrovis partners with customers to meet the evolving expectations of regulatory and government agencies, while effectively navigating supply-chain complexities in global markets.

Our capabilities span sterile antibiotics (APIs and dosage forms), cytotoxic formulations (OSDs, injectables, and topicals), and female hormone products, serving regulated markets across the globe.

We enable safer, smarter, and more accessible medicines - from molecule to market.